Search research articles
Contact Us
Filters
Showing results (11-20 of 219) with videos related to
Page
of 22
Sort By:
Urologie (Heidelberg, Germany)
|
February 10, 2023
[Androgen deprivation therapy plus chemotherapy ± androgen receptor-targeting agents for metastatic hormone-sensitive prostate cancer]
Mike Wenzel, Benedikt Hoeh, Felix K H Chun, et al.
Urologic Oncology
|
March 28, 2015
The effect of age on functional outcomes after radical prostatectomy
Philipp Mandel, Markus Graefen, Uwe Michl, et al.
American Journal of Physiology. Renal Physiology
|
September 8, 2017
Angiotensin II type 1a receptor-deficient mice develop angiotensin II-induced oxidative stress and DNA damage without blood pressure increase
Anna Zimnol, Kerstin Amann, Philipp Mandel, et al.
Urologie (Heidelberg, Germany)
|
August 14, 2024
[Contemporary treatment standards and trends of systemic therapy in metastatic hormone-sensitive prostate cancer-implementing study data in clinical practice]
Mike Wenzel, Séverine Banek, Felix K H Chun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 30, 2025
Reply to "<sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?"
Mike Wenzel, Daniel Groener, Felix K H Chun, et al.
Asian Journal of Andrology
|
September 27, 2017
Radical prostatectomy in patients aged 75 years or older: review of the literature
Philipp Mandel, Thenappan Chandrasekar, Felix K Chun, et al.
World Journal of Urology
|
March 21, 2015
Surgical learning curve for open radical prostatectomy: Is there an end to the learning curve?
Alexander Kretschmer, Philipp Mandel, Alexander Buchner, et al.
Aktuelle Urologie
|
March 19, 2021
[Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program]
Eva Hellmis, Christian Schwentner, Philipp Mandel, et al.
Aktuelle Urologie
|
February 23, 2021
[Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program]
Eva Hellmis, Christian Schwentner, Philipp Mandel, et al.
The Prostate
|
June 16, 2015
Impact of prostate volume on oncologic, perioperative, and functional outcomes after radical prostatectomy
Philipp Mandel, Philipp Weinhold, Uwe Michl, et al.
Page
of 22
Search research articles
Search
Showing results (11-20 of 219) with videos related to
Sort By:
Page
of 22
Urologie (Heidelberg, Germany)
|
February 10, 2023
[Androgen deprivation therapy plus chemotherapy ± androgen receptor-targeting agents for metastatic hormone-sensitive prostate cancer]
Mike Wenzel, Benedikt Hoeh, Felix K H Chun, et al.
Urologic Oncology
|
March 28, 2015
The effect of age on functional outcomes after radical prostatectomy
Philipp Mandel, Markus Graefen, Uwe Michl, et al.
American Journal of Physiology. Renal Physiology
|
September 8, 2017
Angiotensin II type 1a receptor-deficient mice develop angiotensin II-induced oxidative stress and DNA damage without blood pressure increase
Anna Zimnol, Kerstin Amann, Philipp Mandel, et al.
Urologie (Heidelberg, Germany)
|
August 14, 2024
[Contemporary treatment standards and trends of systemic therapy in metastatic hormone-sensitive prostate cancer-implementing study data in clinical practice]
Mike Wenzel, Séverine Banek, Felix K H Chun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 30, 2025
Reply to "<sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?"
Mike Wenzel, Daniel Groener, Felix K H Chun, et al.
Asian Journal of Andrology
|
September 27, 2017
Radical prostatectomy in patients aged 75 years or older: review of the literature
Philipp Mandel, Thenappan Chandrasekar, Felix K Chun, et al.
World Journal of Urology
|
March 21, 2015
Surgical learning curve for open radical prostatectomy: Is there an end to the learning curve?
Alexander Kretschmer, Philipp Mandel, Alexander Buchner, et al.
Aktuelle Urologie
|
March 19, 2021
[Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program]
Eva Hellmis, Christian Schwentner, Philipp Mandel, et al.
Aktuelle Urologie
|
February 23, 2021
[Apalutamide in patients with high-risk M0CRPC: data from the pivotal SPARTAN study and initial experience from a compassionate use program]
Eva Hellmis, Christian Schwentner, Philipp Mandel, et al.
The Prostate
|
June 16, 2015
Impact of prostate volume on oncologic, perioperative, and functional outcomes after radical prostatectomy
Philipp Mandel, Philipp Weinhold, Uwe Michl, et al.
Page
of 22